Free Trial

Kelly Financial Services LLC Purchases New Holdings in The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Kelly Financial Services LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 2,000 shares of the company's stock, valued at approximately $325,000.

Other large investors have also recently bought and sold shares of the company. Aaron Wealth Advisors LLC acquired a new position in shares of Clorox in the 4th quarter valued at approximately $242,000. HB Wealth Management LLC boosted its holdings in shares of Clorox by 12.4% in the fourth quarter. HB Wealth Management LLC now owns 4,588 shares of the company's stock valued at $745,000 after buying an additional 506 shares during the period. Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Somerset Trust Co raised its holdings in shares of Clorox by 5.4% during the fourth quarter. Somerset Trust Co now owns 14,214 shares of the company's stock worth $2,308,000 after acquiring an additional 723 shares during the period. Finally, Merit Financial Group LLC lifted its position in Clorox by 17.3% in the 4th quarter. Merit Financial Group LLC now owns 2,274 shares of the company's stock valued at $369,000 after acquiring an additional 336 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Analysts Set New Price Targets

A number of research firms have issued reports on CLX. Jefferies Financial Group upgraded Clorox from a "hold" rating to a "buy" rating and increased their target price for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Barclays decreased their target price on shares of Clorox from $139.00 to $130.00 and set an "underweight" rating for the company in a research report on Friday. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. JPMorgan Chase & Co. lifted their target price on Clorox from $167.00 to $171.00 and gave the company a "neutral" rating in a research report on Thursday. Finally, DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research report on Monday, November 4th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, Clorox currently has an average rating of "Hold" and an average target price of $156.54.

Get Our Latest Research Report on CLX

Clorox Stock Performance

Shares of NYSE CLX traded down $0.16 during midday trading on Friday, hitting $160.31. 937,465 shares of the company's stock were exchanged, compared to its average volume of 960,748. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company's 50 day moving average price is $164.25 and its 200 day moving average price is $156.54. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $19.84 billion, a PE ratio of 55.86, a price-to-earnings-growth ratio of 2.90 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company's revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.49 earnings per share. As a group, analysts predict that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.04%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio is presently 170.04%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines